Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Home - Medesis |
Description | An innovative Medesis Pharma is a clinical-stage Pharmaceutical Biotechnology company developing innovative technology |
Keywords | N/A |
WebSite | medesispharma.com |
Host IP | 195.114.18.148 |
Location | France |
Site | Rank |
US$639,262
Last updated: 2023-05-14 20:25:56
medesispharma.com has Semrush global rank of 16,557,067. medesispharma.com has an estimated worth of US$ 639,262, based on its estimated Ads revenue. medesispharma.com receives approximately 73,761 unique visitors each day. Its web server is located in France, with IP address 195.114.18.148. According to SiteAdvisor, medesispharma.com is safe to visit. |
Purchase/Sale Value | US$639,262 |
Daily Ads Revenue | US$591 |
Monthly Ads Revenue | US$17,703 |
Yearly Ads Revenue | US$212,432 |
Daily Unique Visitors | 4,918 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
medesispharma.com. | A | 7196 | IP: 195.114.18.148 |
medesispharma.com. | NS | 7200 | NS Record: dns50.domaine.fr. |
medesispharma.com. | NS | 7200 | NS Record: dns2.french-connexion.com. |
medesispharma.com. | MX | 7200 | MX Record: 50 ASPMX4.GOOGLEMAIL.com. |
medesispharma.com. | MX | 7200 | MX Record: 50 ASPMX5.GOOGLEMAIL.com. |
medesispharma.com. | MX | 7200 | MX Record: 0 ASPMX.L.GOOGLE.com. |
medesispharma.com. | MX | 7200 | MX Record: 5 ALT1.ASPMX.L.GOOGLE.com. |
medesispharma.com. | MX | 7200 | MX Record: 5 ALT2.ASPMX.L.GOOGLE.com. |
medesispharma.com. | MX | 7200 | MX Record: 10 ASPMX2.GOOGLEMAIL.com. |
medesispharma.com. | MX | 7200 | MX Record: 10 ASPMX3.GOOGLEMAIL.com. |
medesispharma.com. | TXT | 7200 | TXT Record: nsnb52wq73tc4tzcg7jc6ygrylycmc2m |
medesispharma.com. | TXT | 7200 | TXT Record: v=spf1 include:_spf.google.com ~all |
Corporate General presentation Historical Governance Supervisory board Scientific Advisory board Technology Description Advantages Historical Pipeline Clinical Alzheimer’s disease Pre-clinical Neurology Cancer Nuclear Investors Share information Press release Reports and documents Regulated information General Meetings Agenda & Contact Scientific publications Contacts Select Page An innovative technology to treat serious illnesses Buccal administration to deliver pharmaceutical active ingredients to all cells: Interfering RNAs, metal ions, peptides … With AONYS delivery platform, Medesis Pharma paves the way for new treatments ! Learn More News Medesis Pharma signs a partnership with Partner International, world leader in transactions between biotechs and pharmaceutical laboratories April, 2023 Read more Medesis pharma sets up bond financing for a potential maximum nominal amount of 2,500,000 euros March, 2023 Read more New patent filed protecting the technical optimization of the |
HTTP/1.1 301 Moved Permanently date: Thu, 23 Dec 2021 23:52:42 GMT server: Apache location: https://www.medesispharma.com/ content-type: text/html; charset=iso-8859-1 set-cookie: PHPNET-MNO=11122|YcULz|YcULz; path=/; HttpOnly |
Domain Name: MEDESISPHARMA.COM Registry Domain ID: 125218668_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corehub.net Registrar URL: http://corehub.net Updated Date: 2021-06-21T12:04:34Z Creation Date: 2004-07-20T12:31:38Z Registry Expiry Date: 2022-07-20T12:31:38Z Registrar: Corehub, S.R.L. Registrar IANA ID: 15 Registrar Abuse Contact Email: abuse@corehub.net Registrar Abuse Contact Phone: +34935275235 Domain Status: ok https://icann.org/epp#ok Name Server: DNS2.FRENCH-CONNEXION.COM Name Server: DNS5.FRENCH-CONNEXION.COM Name Server: DNS50.DOMAINE.FR DNSSEC: unsigned >>> Last update of whois database: 2021-12-27T07:26:44Z <<< |